Brand-name Soolantra carries an average retail price around $384 for a single 45-gram tube, making it one of the pricier topical treatments for rosacea. The high cost comes down to a combination of brand-name pricing by its manufacturer Galderma, extensive patent protection, and inconsistent insurance coverage. The good news: generic versions now exist, and several discount programs can cut that price dramatically.
What Drives the Brand-Name Price
Soolantra is a 1% ivermectin cream approved specifically for the inflammatory bumps and redness of rosacea. While ivermectin itself is an old, inexpensive drug used widely in oral form, the topical cream formulation required its own clinical development, FDA approval process, and patent portfolio. Galderma holds multiple patents on the cream, some extending as far as March 2034. That patent wall gives the company significant control over pricing, even though the first generic competitors entered the market in 2019.
The cream also occupies a somewhat niche position. Rosacea affects roughly 16 million Americans, but only a fraction need or use prescription topical ivermectin. Smaller patient populations generally mean higher per-unit prices, since the manufacturer spreads development costs across fewer prescriptions. In a head-to-head trial, ivermectin cream outperformed the older standard treatment (metronidazole gel), with 84.9% of patients reaching clear or almost-clear skin compared to 75.4% on metronidazole. That clinical edge gives Galderma leverage to price Soolantra as a premium option.
Generic Versions Are Available, but Prices Vary
The FDA has approved generic ivermectin 1% cream from three manufacturers: Teva (approved 2019), Padagis (2020), and Zydus Lifesciences (2022). Several of these generics have been actively marketed since 2023 and 2024. With a GoodRx coupon, generic ivermectin cream can cost as little as $94, a 76% discount off the brand-name retail price.
That said, generic availability doesn’t always translate to low prices at every pharmacy. Not all pharmacies stock every generic, and pricing can swing widely depending on your location and which manufacturer’s version is in stock. If your pharmacy quotes a high price, it’s worth checking competing pharmacies or using a discount coupon tool to compare.
Insurance Often Makes It Harder, Not Easier
You might expect insurance to bring the cost down, but many plans create their own barriers. Blue Cross Blue Shield of Texas, for example, lists generic ivermectin cream as “non-preferred,” meaning higher copays and possible restrictions like prior authorization. The brand-name version is often not covered at all. This pattern is common across insurers: even when the generic is technically on the formulary, it may sit on a higher tier that leaves you paying $50 to $100 or more out of pocket.
Prior authorization adds another layer of frustration. Your prescriber may need to document that you’ve tried and failed a cheaper treatment like metronidazole before the insurer will approve coverage for ivermectin cream. That process can take days or weeks, and approval isn’t guaranteed.
Ways to Lower the Cost
Galderma runs a savings program called CareConnect that can significantly reduce what you pay. If you have commercial insurance that covers Soolantra without restrictions, the program drops your copay to $20. If your insurance doesn’t cover it, or if you’re paying cash, the price through the program is $90. The catch: patients on government insurance (Medicare, Medicaid, Tricare, VA) aren’t eligible. And in California and Massachusetts, the offer becomes void if a cheaper generic equivalent is available.
Beyond the manufacturer program, your most reliable path to a lower price is asking your pharmacy to fill the generic version and using a free discount coupon from sites like GoodRx or RxSaver. Comparing prices across pharmacies (including mail-order options) can easily save you $100 or more per tube.
Why Veterinary Ivermectin Isn’t a Safe Shortcut
The high price of Soolantra has pushed some rosacea patients toward veterinary ivermectin paste, commonly sold as horse dewormer. This is a genuinely risky workaround. Horse paste contains ivermectin at 1.87%, nearly double the concentration in Soolantra, and includes inactive ingredients like titanium dioxide, hydrogenated castor oil, and butylhydroxyanisole that were never tested for use on human facial skin. The way ivermectin absorbs through skin at that higher concentration is simply unknown. Soolantra’s safety profile is based on its specific 1% formulation and its specific base ingredients, and substituting a veterinary product removes those safeguards entirely.